Adage Capital Partners’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Adage Capital Partners’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-87,777	Closed	-$7.9K	–	1073
2022 Q4	$7.9K	Hold	87,777	–	–	﹤0.01%	954
2022 Q3	$15K	Hold	87,777	–	–	﹤0.01%	1027
2022 Q2	$20K	Hold	87,777	–	–	﹤0.01%	1066
2022 Q1	$37K	Hold	87,777	–	–	﹤0.01%	1072
2021 Q4	$64K	Hold	87,777	–	–	﹤0.01%	1014
2021 Q3	$62K	Hold	87,777	–	–	﹤0.01%	1014
2021 Q2	$89K	Buy	+87,777	New	+$69.5K	﹤0.01%	1008

Adage Capital Partners's MSACW Position: Q1 2023 in Review

Adage Capital Partners sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 87,777 shares — an estimated $7.9K sold.

Adage Capital Partners first reported a position in MSACW in Q2 2021 and held it in 7 quarters. The position peaked at $89K in Q2 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Adage Capital Partners reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Adage Capital Partners sold 87,777 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $7.9K.
Adage Capital Partners first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Adage Capital Partners's Medicus Sciences Acquisition Corp. Warrant position peaked at $89K in Q2 2021.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.